468 related articles for article (PubMed ID: 34845968)
21. FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity.
Dong K; Chen W; Pan X; Wang H; Sun Y; Qian C; Chen W; Wang C; Yang F; Cui X
BMC Cancer; 2022 Feb; 22(1):140. PubMed ID: 35120484
[TBL] [Abstract][Full Text] [Related]
22. IGLL5 is correlated with tumor-infiltrating immune cells in clear cell renal cell carcinoma.
Xia ZN; Wang XY; Cai LC; Jian WG; Zhang C
FEBS Open Bio; 2021 Mar; 11(3):898-910. PubMed ID: 33449444
[TBL] [Abstract][Full Text] [Related]
23. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
[TBL] [Abstract][Full Text] [Related]
24. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG
Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816
[TBL] [Abstract][Full Text] [Related]
25. A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.
Gao J; Ye F; Han F; Jiang H; Zhang J
Front Immunol; 2022; 13():956679. PubMed ID: 36177018
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive bioinformatics analysis of KIF20A as a prognosis biomarker for clear cell renal cell carcinoma.
Xie C; Yiu W; Mo Y
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):116-124. PubMed ID: 38650144
[TBL] [Abstract][Full Text] [Related]
27. The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma.
Bai S; Wu Y; Yan Y; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J
Int J Med Sci; 2020; 17(18):2917-2925. PubMed ID: 33173412
[No Abstract] [Full Text] [Related]
28. Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma.
Xu WH; Xu Y; Tian X; Anwaier A; Liu WR; Wang J; Zhu WK; Cao DL; Wang HK; Shi GH; Qu YY; Zhang HL; Ye DW
J Cell Mol Med; 2020 Aug; 24(16):9012-9027. PubMed ID: 32567187
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310
[TBL] [Abstract][Full Text] [Related]
30. Construction of an immune-related prognostic model by exploring the tumor microenvironment of clear cell renal cell carcinoma.
He J; Zhong Y; Sun Y; Xie C; Yu T
Anal Biochem; 2022 Apr; 643():114567. PubMed ID: 35122734
[TBL] [Abstract][Full Text] [Related]
31. Identification of Key Genes of Prognostic Value in Clear Cell Renal Cell Carcinoma Microenvironment and a Risk Score Prognostic Model.
Zhao E; Bai X
Dis Markers; 2020; 2020():8852388. PubMed ID: 32952743
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of infiltrating immune cells in clear cell renal cell carcinoma (ccRCC).
Liu S; Li S; Wang Y; Wang F; Zhang L; Xian S; Yang D; Yuan M; Dai F; Zhao X; Liu Y; Jin Y; Zeng Z; Mahgoub OKA; Zhou C; Cheng Y
J Cell Biochem; 2020 Mar; 121(3):2571-2581. PubMed ID: 31823423
[TBL] [Abstract][Full Text] [Related]
33. TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma.
Pan Q; Cheng G; Liu Y; Xu T; Zhang H; Li B
Int J Oncol; 2020 May; 56(5):1101-1114. PubMed ID: 32319572
[TBL] [Abstract][Full Text] [Related]
34. Stemness related lncRNAs signature for the prognosis and tumor immune microenvironment of ccRCC patients.
Zhang M; Zhang J; Liang X; Zhang M
BMC Med Genomics; 2024 May; 17(1):150. PubMed ID: 38822402
[TBL] [Abstract][Full Text] [Related]
35. Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma.
He Z; Gu Y; Yang H; Fu Q; Zhao M; Xie Y; Liu Y; Du W
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11661-11678. PubMed ID: 37402968
[TBL] [Abstract][Full Text] [Related]
36. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.
Cui Y; Zhou Z; Chai Y; Zhang Y
J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma.
Liu T; Sui J; Zhang Y; Zhang XM; Wu WJ; Yang S; Xu SY; Hong WW; Peng H; Yin LH; Pu YP; Liang GY
Oncol Rep; 2018 Sep; 40(3):1503-1514. PubMed ID: 30015930
[TBL] [Abstract][Full Text] [Related]
38. LAGE3 correlates with tumorigenic immune infiltrates in the clear cell renal cell carcinoma microenvironment.
Dong X; Gu DN; Wang O; Ye Z
Int Immunopharmacol; 2020 Oct; 87():106793. PubMed ID: 32683301
[TBL] [Abstract][Full Text] [Related]
39. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y
BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688
[TBL] [Abstract][Full Text] [Related]
40. Prognostic and Immune Infiltration Signatures of GIMAP Family Genes in Clear Cell Renal Cell Carcinoma.
Zhang M; Zhang X; Hou J; Liang X; Zhang M
Front Biosci (Landmark Ed); 2023 Nov; 28(11):308. PubMed ID: 38062816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
